KNOW LABS

Know Labs is a non-invasive diagnostic technology platform that uses radio waves to identify and measure molecules in the body. Its Bio-RFID™ platform uses electromagnetic energy and can be integrated into a variety of wearable, mobile, or bench-top form factors. The first application of its technology is a glucose monitor device, the UBAND. It will provide the user with real-time information on their blood glucose levels, assisting billions of people with diabetes and pre-diabetes to manage this medical condition. Know Labs is a public company whose shares trade under the stock symbol KNWN. The company was incorporated in 2003 and is based in Seattle, Washington.